Areeba Memon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Areeba Memon has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Areeka Irfan
Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication - Beena Kumari
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication Bilal Razaque Memon
Liaquat University Hospital, Hyderabad, Pakistan
1 shared publicationGhulam Nabi Pathan
Department of Physiology, Indus Medical College – Tando Muhammad Khan, Pakistan
1 shared publication- Ishaque Hameed
Department of Medicine, MedStar Health, Baltimore, MD, USA
1 shared publication - Khalida Shaikh
Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
1 shared publication
Latest Publications
- Open Access
- 19 September 2023
- Published by Taylor & Francis in Future Science OA
- Vol. 9 (10) , FSO898
Efficacy and Safety of Mavacamten in Treatment of Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
Aim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. Methods & materials: A search was conducted using PubMed, Cochran... Plain language summary Mavacamten is a recently introduced medication that relaxes the heart muscle and is indicated for patients with hypertrophic cardiomyopathy (a disease in which parts of the h... Tweetable abstract The efficacy and safety of mavacamten, a novel drug, was assessed in patients of hypertrophic cardiomyopathy. It was noted that mavacamten significantly improved NYHA class, KCCQ... Graphical abstract
- 19 September 2023
- Published by Taylor & Francis in Future Science OA
- Vol. 9 (10) , FSO898
Open AccessEfficacy and Safety of Mavacamten in Treatment of Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
Aim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. Methods & materials: A search was conducted using PubMed, Cochran... Plain language summary Mavacamten is a recently introduced medication that relaxes the heart muscle and is indicated for patients with hypertrophic cardiomyopathy (a disease in which parts of the h... Tweetable abstract The efficacy and safety of mavacamten, a novel drug, was assessed in patients of hypertrophic cardiomyopathy. It was noted that mavacamten significantly improved NYHA class, KCCQ... Graphical abstract
- Open Access
- 12 March 2022
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 27-32
Association of Inflammatory Markers with Metabolic Syndrome among Pre & Post-menopausal Women
Background: Metabolic Syndrome (MetS) comprises of an array of clinical, physiological, metabolic and biochemical disturbances; associated with a systemic inflammatory response. The debilitating condition entails high morbidity and mortality and thus it is important to identify and resolve it timely; a goal which may be achieved with the help of biomarkers. Fibrinogen and hsCRP; highly sensitive C-reactive protein, are found to be increased in acute inflammations. The raised quantity is indicative of underlying inflammatory states and thus may be relevant to MetS. Objectives: To determine the association of inflammatory markers with metabolic syndrome among pre & post-menopausal women. Materials and Methods: This cross-sectional analysis was carried out on a sample of 278 women (aged at or above 25 years) presenting to the Outpatient Department of General Medicine and the Obstetrics – Gynecology at Liaquat University Hospital (Hyderabad) from 01-02-2020 to 01-10-2020. Data was collected using a structured interview-based proforma which include information about biodata and sociodemographic details of research participants and biochemical analysis (CRP, DLC and fibrinogen and insulin measurement). Results: In this study a cumulative MetS prevalence was found out to be around 60% (63.7% as per IDF criteria and (57.6% as per ATP-III classifications). Women with MetS had higher levels of CRP and fibrinogen. Women with high fibrinogen levels and CRP suffered with more type of metabolic abnormalities. Conclusion: The findings of this studies showed that with total body fat and fat percentage, body mass-index, have a positive association with the studied inflammatory markers (CRP and fibrinogen).
- 12 March 2022
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 27-32
Open AccessAssociation of Inflammatory Markers with Metabolic Syndrome among Pre & Post-menopausal Women
Background: Metabolic Syndrome (MetS) comprises of an array of clinical, physiological, metabolic and biochemical disturbances; associated with a systemic inflammatory response. The debilitating condition entails high morbidity and mortality and thus it is important to identify and resolve it timely; a goal which may be achieved with the help of biomarkers. Fibrinogen and hsCRP; highly sensitive C-reactive protein, are found to be increased in acute inflammations. The raised quantity is indicative of underlying inflammatory states and thus may be relevant to MetS. Objectives: To determine the association of inflammatory markers with metabolic syndrome among pre & post-menopausal women. Materials and Methods: This cross-sectional analysis was carried out on a sample of 278 women (aged at or above 25 years) presenting to the Outpatient Department of General Medicine and the Obstetrics – Gynecology at Liaquat University Hospital (Hyderabad) from 01-02-2020 to 01-10-2020. Data was collected using a structured interview-based proforma which include information about biodata and sociodemographic details of research participants and biochemical analysis (CRP, DLC and fibrinogen and insulin measurement). Results: In this study a cumulative MetS prevalence was found out to be around 60% (63.7% as per IDF criteria and (57.6% as per ATP-III classifications). Women with MetS had higher levels of CRP and fibrinogen. Women with high fibrinogen levels and CRP suffered with more type of metabolic abnormalities. Conclusion: The findings of this studies showed that with total body fat and fat percentage, body mass-index, have a positive association with the studied inflammatory markers (CRP and fibrinogen).